MYLAN 217 250 (Tolazamide 250 mg)
Pill imprint MYLAN 217 250 has been identified as Tolazamide 250 mg.
Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 250 mg
- 10.00 mm
- Prescription only
sodium lauryl sulfate
More about tolazamide
- Other brands: Tolinase
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.